Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03280589 · ClinicalTrials.gov registry record · Early Phase 1
Pranayama Practice on the Autonomic Nervous System
A Early Phase 1 study, sponsored by National University of Natural Medicine.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 25
- Enrollment target
NCT03280589: Completed Early Phase 1 study, sponsored by National University of Natural Medicine.
NCT03280589 is a Early Phase 1 study that has completed, run by National University of Natural Medicine. The registered enrollment target is 25 participants, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (53% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03280589, a Early Phase 1 study, has completed, sponsored by National University of Natural Medicine.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 25 participants
- Enrollment target
Study Summary
The proposed study design will be a randomized, cross-over trial testing different pranayama breathing interventions. Participants (N=40) will perform each of the following five interventions in a randomly assigned order: (1) internal-paced pranayama intervention (Sheetali/Sheetkari for 10 minutes each) (2) internal-paced deep breathing control (3) external-paced pranayama intervention at a rate of 6 bpm (4) external-paced deep breathing at a rate of 6 bpm (5) sitting quietly with no external instruction.
Primary Outcome
Analysis of EKG spectra before and after the session
Interventions
- OTHER Sheetali/Sheekari Pranayama
- OTHER Sitting Quietly
- OTHER Deep breathing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2017-08-15 |
| Est. Completion | 2021-07-21 |
| Phase | Early Phase 1 |
What the finished NCT03280589 record still lists
NCT03280589 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (53% lower).
The record links to 0 conditions, and to 3 interventions - of which Sheetali/Sheekari Pranayama is the first listed.
NCT03280589 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03280589 about?
NCT03280589 is a clinical study titled "Pranayama Practice on the Autonomic Nervous System". The proposed study design will be a randomized, cross-over trial testing different pranayama breathing interventions. Participants (N=40) will perform each of the following five interventions in a randomly assigned order: (1) internal-paced pranayama intervention (Sheetali/Sheetkari for 10 minutes e...
What is the current status of trial NCT03280589?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 25 participants. The study started on 2017-08-15. Estimated completion is 2021-07-21.
What interventions are being tested in trial NCT03280589?
The interventions under investigation include: Sheetali/Sheekari Pranayama (OTHER), Sitting Quietly (OTHER), Deep breathing (OTHER).
Who is sponsoring clinical trial NCT03280589?
This trial is sponsored by National University of Natural Medicine, which has 30 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03280589's enrollment target sits among peer trials
25 1000th of 2000 higher than 965 of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI